Reply to post: Clearly states the first batch is manufactured in EU, not UK

Clearly states the first batch is manufactured in EU, not UK

The contract clearly states that AstraZenica has to try to manufacture the 300m doses of vaccine for the EU, in the EU.

Section 5.1 says "AstraZenica shall use it's Best Reasonable Efforts to manufacture the Initial Europe Doses within the EU for distribution, and to deliver to the Distribution Hubs....".

Let me repeat that, it has to try it's best to "manufacture the Initial Europe Doses within the EU". And "the EU" specifically does not include the UK (see Section 5.4, which says "the EU [...] for the purpose of this Section 5.4 only shall include the United Kingdom" - which makes it clear that in *other* sections the EU does NOT include the United Kingdom). The "Initial Europe Doses" means the first 300 million doses, which are what they're currently trying to get. Note this doesn't apply to the 100 million doses that the EU can choose to buy after that - but it can't take delivery of the 100 million extra doses until after the first 300 million doses have been delivered.

Now, it does also have to "use it's Best Reasonable Efforts to manufacture the Vaccine at manufacturing sites located within the EU (which, for the purpose of this Section 5.4 only shall include the United Kingdom)". However, nothing says it has to give doses manufactured in the UK to the EU. And 5.1 is fairly explicit about how the initial batch of 300 million doses should be manufactured in the EU. Presumably this section is talking about the following 100 million+ doses.